Minerva Neurosciences (NERV) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock, up from $4.00.
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
Minerva Neurosciences files $200M mixed shelf registration [Seeking Alpha]
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates [Yahoo! Finance]
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates